기업명 | 주식 심볼 | 시장 | 주식 타입 |
---|---|---|---|
Reviva Pharmaceuticals Holdings Inc | RVPH | 나스닥 | 보통주 |
개장가 | 저가 | 고가 | 종가 | 전일 종가 |
---|---|---|---|---|
2.94 |
최근 뉴스
일자 | 시간 | 출처 | 제목 |
---|---|---|---|
17/02/2024 | 06:32 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
14/02/2024 | 14:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
14/02/2024 | 07:00 | EDGAR2 | Form 424B4 - Prospectus [Rule 424(b)(4)] |
03/02/2024 | 06:38 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
18/11/2023 | 06:05 | EDGAR2 | Form 8-K - Current report |
18/11/2023 | 06:03 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
15/11/2023 | 06:12 | EDGAR2 | Form 8-K - Current report |
30/10/2023 | 21:20 | EDGAR2 | Form 8-K - Current report |
05/10/2023 | 06:03 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
05/10/2023 | 06:02 | EDGAR2 | Form 8-K - Current report |
17/08/2023 | 19:30 | EDGAR2 | Form 8-K - Current report |
15/08/2023 | 05:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
15/08/2023 | 05:15 | EDGAR2 | Form 8-K - Current report |
25/07/2023 | 05:16 | EDGAR2 | Form 8-K - Current report |